Soc. Generale Call 36 OMV 20.12.2.../ DE000SY61Q73 /
2024-10-11 9:48:42 PM | Chg.+0.010 | Bid2024-10-11 | Ask2024-10-11 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.410EUR | +2.50% | 0.410 Bid Size: 7,400 |
0.440 Ask Size: 7,400 |
OMV AG | 36.00 EUR | 2024-12-20 | Call |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center